Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Protein Disulfide-Isomerases | 23 | 2019 | 210 | 7.020 |
Why?
|
Thrombosis | 49 | 2018 | 2956 | 3.980 |
Why?
|
Thromboplastin | 19 | 2020 | 288 | 3.560 |
Why?
|
Blood Platelets | 31 | 2019 | 2485 | 3.230 |
Why?
|
Fibrin | 17 | 2018 | 515 | 2.080 |
Why?
|
Blood Coagulation | 22 | 2019 | 1162 | 2.060 |
Why?
|
P-Selectin | 15 | 2018 | 599 | 1.370 |
Why?
|
Platelet Activation | 11 | 2018 | 646 | 1.160 |
Why?
|
Integrin beta3 | 4 | 2015 | 120 | 1.050 |
Why?
|
Cell-Derived Microparticles | 5 | 2012 | 161 | 0.920 |
Why?
|
Thrombin | 6 | 2018 | 600 | 0.900 |
Why?
|
beta 2-Glycoprotein I | 2 | 2014 | 28 | 0.840 |
Why?
|
Endothelial Cells | 8 | 2019 | 3586 | 0.790 |
Why?
|
Antiphospholipid Syndrome | 3 | 2017 | 167 | 0.750 |
Why?
|
Lasers | 7 | 2015 | 952 | 0.720 |
Why?
|
Blood Coagulation Disorders, Inherited | 1 | 2020 | 19 | 0.720 |
Why?
|
1-Carboxyglutamic Acid | 8 | 2006 | 19 | 0.680 |
Why?
|
Arterioles | 5 | 2012 | 252 | 0.670 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 5 | 2017 | 578 | 0.650 |
Why?
|
Complement Pathway, Mannose-Binding Lectin | 1 | 2019 | 28 | 0.650 |
Why?
|
Frameshift Mutation | 1 | 2020 | 393 | 0.620 |
Why?
|
Vitamin K | 3 | 2014 | 314 | 0.610 |
Why?
|
Rutin | 2 | 2015 | 16 | 0.610 |
Why?
|
Microscopy, Video | 7 | 2012 | 242 | 0.600 |
Why?
|
Disulfides | 4 | 2019 | 467 | 0.590 |
Why?
|
Factor VIIIa | 3 | 2008 | 16 | 0.590 |
Why?
|
Membrane Glycoproteins | 11 | 2010 | 3713 | 0.590 |
Why?
|
Lectins | 1 | 2019 | 490 | 0.550 |
Why?
|
Factor IXa | 2 | 2008 | 19 | 0.530 |
Why?
|
Disease Models, Animal | 14 | 2020 | 18388 | 0.520 |
Why?
|
Platelet Aggregation | 7 | 2018 | 772 | 0.510 |
Why?
|
Endothelium | 3 | 2017 | 768 | 0.510 |
Why?
|
Blood Vessels | 2 | 2016 | 1112 | 0.500 |
Why?
|
Hermanski-Pudlak Syndrome | 1 | 2015 | 20 | 0.490 |
Why?
|
Rodenticides | 1 | 2014 | 21 | 0.490 |
Why?
|
Phenprocoumon | 1 | 2013 | 19 | 0.460 |
Why?
|
Acenocoumarol | 1 | 2013 | 18 | 0.450 |
Why?
|
Antibodies, Antiphospholipid | 1 | 2014 | 72 | 0.450 |
Why?
|
Anticoagulants | 3 | 2014 | 4840 | 0.450 |
Why?
|
Protein Multimerization | 1 | 2019 | 980 | 0.440 |
Why?
|
Fibrinolytic Agents | 6 | 2017 | 2082 | 0.440 |
Why?
|
Factor VIII | 4 | 2010 | 349 | 0.440 |
Why?
|
Blood Coagulation Disorders | 2 | 2014 | 350 | 0.440 |
Why?
|
Vascular System Injuries | 1 | 2017 | 251 | 0.430 |
Why?
|
Catalytic Domain | 7 | 2019 | 709 | 0.430 |
Why?
|
Animals | 68 | 2020 | 169418 | 0.410 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2013 | 246 | 0.410 |
Why?
|
Conotoxins | 4 | 2006 | 20 | 0.400 |
Why?
|
Quercetin | 3 | 2019 | 96 | 0.400 |
Why?
|
Kinetics | 11 | 2019 | 6348 | 0.400 |
Why?
|
Blood Coagulation Factors | 4 | 2017 | 366 | 0.390 |
Why?
|
Platelet Adhesiveness | 3 | 2007 | 154 | 0.390 |
Why?
|
Mice, Inbred C57BL | 24 | 2020 | 22365 | 0.380 |
Why?
|
Urokinase-Type Plasminogen Activator | 5 | 2017 | 325 | 0.370 |
Why?
|
Glycoproteins | 1 | 2019 | 2206 | 0.370 |
Why?
|
Carbon-Carbon Ligases | 3 | 2007 | 19 | 0.350 |
Why?
|
Enoxaparin | 1 | 2012 | 391 | 0.350 |
Why?
|
Flow Cytometry | 2 | 2012 | 5904 | 0.340 |
Why?
|
Plasminogen Activator Inhibitor 1 | 3 | 2017 | 280 | 0.330 |
Why?
|
Mice | 41 | 2020 | 82045 | 0.320 |
Why?
|
Hemorrhage | 3 | 2016 | 3458 | 0.290 |
Why?
|
Substrate Specificity | 4 | 2019 | 1775 | 0.280 |
Why?
|
Mice, Knockout | 15 | 2020 | 14480 | 0.280 |
Why?
|
von Willebrand Factor | 2 | 2010 | 679 | 0.280 |
Why?
|
Mollusca | 2 | 2005 | 40 | 0.270 |
Why?
|
Thromboembolism | 2 | 2012 | 1006 | 0.270 |
Why?
|
Oxidation-Reduction | 3 | 2019 | 2232 | 0.270 |
Why?
|
Autoantibodies | 2 | 2014 | 2131 | 0.260 |
Why?
|
Leukocytes | 5 | 2007 | 2030 | 0.250 |
Why?
|
Warfarin | 1 | 2013 | 1493 | 0.240 |
Why?
|
Calcium | 9 | 2010 | 5793 | 0.240 |
Why?
|
Integrin alphaVbeta3 | 2 | 2017 | 103 | 0.230 |
Why?
|
Protein Binding | 12 | 2017 | 9376 | 0.230 |
Why?
|
Models, Molecular | 9 | 2017 | 5443 | 0.230 |
Why?
|
Cell Membrane | 7 | 2018 | 3664 | 0.230 |
Why?
|
Factor IX | 1 | 2004 | 76 | 0.230 |
Why?
|
Protein Structure, Tertiary | 12 | 2016 | 3790 | 0.220 |
Why?
|
Vitronectin | 2 | 2017 | 41 | 0.220 |
Why?
|
Microcirculation | 6 | 2006 | 1282 | 0.210 |
Why?
|
Particle Size | 4 | 2011 | 1654 | 0.200 |
Why?
|
Selectins | 1 | 2002 | 101 | 0.200 |
Why?
|
Neoplasms | 6 | 2019 | 22386 | 0.200 |
Why?
|
Dermatitis, Contact | 1 | 2002 | 133 | 0.200 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2004 | 447 | 0.200 |
Why?
|
Venous Thromboembolism | 2 | 2019 | 1884 | 0.200 |
Why?
|
Protein Processing, Post-Translational | 5 | 2005 | 1969 | 0.200 |
Why?
|
Humans | 62 | 2020 | 768451 | 0.190 |
Why?
|
Phenylalanine | 1 | 2003 | 366 | 0.190 |
Why?
|
Models, Biological | 6 | 2016 | 9505 | 0.190 |
Why?
|
Collagen | 2 | 2009 | 2646 | 0.190 |
Why?
|
Leukocyte Rolling | 3 | 2007 | 69 | 0.180 |
Why?
|
Peptide Chain Termination, Translational | 1 | 2020 | 29 | 0.180 |
Why?
|
Vasculitis | 1 | 2005 | 524 | 0.180 |
Why?
|
Enzyme Inhibitors | 4 | 2016 | 3734 | 0.180 |
Why?
|
Mollusk Venoms | 3 | 2004 | 19 | 0.180 |
Why?
|
Cysteine Endopeptidases | 1 | 2003 | 551 | 0.180 |
Why?
|
Peptide Fragments | 5 | 2017 | 5152 | 0.170 |
Why?
|
Genotype | 2 | 2019 | 13047 | 0.170 |
Why?
|
Blotting, Western | 3 | 2015 | 5042 | 0.170 |
Why?
|
Codon, Nonsense | 1 | 2020 | 287 | 0.160 |
Why?
|
Endothelium, Vascular | 7 | 2015 | 4425 | 0.160 |
Why?
|
Haploinsufficiency | 1 | 2020 | 336 | 0.150 |
Why?
|
Amino Acid Sequence | 11 | 2016 | 13452 | 0.150 |
Why?
|
Recombinant Proteins | 7 | 2018 | 6527 | 0.150 |
Why?
|
Inhibitory Concentration 50 | 2 | 2016 | 467 | 0.150 |
Why?
|
Myosin Heavy Chains | 1 | 2019 | 404 | 0.150 |
Why?
|
Microscopy, Fluorescence | 4 | 2009 | 2640 | 0.150 |
Why?
|
Receptors, Proteinase-Activated | 2 | 2008 | 19 | 0.150 |
Why?
|
Microscopy, Confocal | 3 | 2012 | 1977 | 0.140 |
Why?
|
Bone Marrow Cells | 2 | 2004 | 2415 | 0.140 |
Why?
|
Cells, Cultured | 6 | 2017 | 19041 | 0.140 |
Why?
|
Microscopy | 1 | 2002 | 909 | 0.140 |
Why?
|
Bone Marrow Transplantation | 3 | 2012 | 2702 | 0.140 |
Why?
|
Crystallography, X-Ray | 7 | 2016 | 1987 | 0.140 |
Why?
|
Catalysis | 1 | 2019 | 769 | 0.140 |
Why?
|
Cell Movement | 4 | 2009 | 5223 | 0.140 |
Why?
|
Drug Design | 4 | 2017 | 1050 | 0.140 |
Why?
|
Base Sequence | 5 | 2020 | 12428 | 0.130 |
Why?
|
Surface Plasmon Resonance | 2 | 2015 | 271 | 0.130 |
Why?
|
L-Selectin | 3 | 2007 | 212 | 0.130 |
Why?
|
Transplantation Chimera | 2 | 2012 | 594 | 0.130 |
Why?
|
Molecular Sequence Data | 10 | 2007 | 17647 | 0.130 |
Why?
|
Blood Platelet Disorders | 1 | 2016 | 60 | 0.130 |
Why?
|
Calorimetry | 1 | 2015 | 132 | 0.130 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2019 | 3665 | 0.120 |
Why?
|
Scattering, Small Angle | 1 | 2015 | 63 | 0.120 |
Why?
|
X-Ray Diffraction | 1 | 2015 | 418 | 0.120 |
Why?
|
Binding Sites | 3 | 2015 | 6030 | 0.120 |
Why?
|
DNA, Complementary | 4 | 2006 | 1992 | 0.110 |
Why?
|
Cell Degranulation | 1 | 2015 | 277 | 0.110 |
Why?
|
Adenosine Diphosphate | 1 | 2015 | 423 | 0.110 |
Why?
|
Heterozygote | 1 | 2020 | 2792 | 0.110 |
Why?
|
Hemostasis | 1 | 2016 | 470 | 0.110 |
Why?
|
Exocytosis | 1 | 2015 | 323 | 0.110 |
Why?
|
E-Selectin | 3 | 2009 | 578 | 0.110 |
Why?
|
Lymphocyte Activation | 2 | 2010 | 5495 | 0.110 |
Why?
|
Algorithms | 1 | 2013 | 14158 | 0.100 |
Why?
|
Mice, Mutant Strains | 3 | 2012 | 1755 | 0.100 |
Why?
|
Genetic Association Studies | 2 | 2019 | 2742 | 0.100 |
Why?
|
Prothrombin | 2 | 2011 | 192 | 0.100 |
Why?
|
Protein Folding | 1 | 2016 | 875 | 0.100 |
Why?
|
Apyrase | 1 | 2015 | 374 | 0.100 |
Why?
|
Cell Adhesion | 5 | 2009 | 3103 | 0.100 |
Why?
|
Vesicular Transport Proteins | 1 | 2015 | 377 | 0.100 |
Why?
|
Peptides, Cyclic | 2 | 2004 | 393 | 0.100 |
Why?
|
Ferric Compounds | 3 | 2009 | 379 | 0.100 |
Why?
|
CHO Cells | 2 | 2012 | 1382 | 0.100 |
Why?
|
Mice, 129 Strain | 1 | 2012 | 369 | 0.090 |
Why?
|
Hemoglobinuria, Paroxysmal | 1 | 2012 | 96 | 0.090 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2012 | 325 | 0.090 |
Why?
|
Neoplasm Proteins | 1 | 2003 | 3611 | 0.090 |
Why?
|
Chlorides | 3 | 2009 | 663 | 0.090 |
Why?
|
Flavonoids | 1 | 2014 | 447 | 0.090 |
Why?
|
Factor Xa | 2 | 2018 | 166 | 0.090 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2012 | 425 | 0.090 |
Why?
|
Cricetinae | 2 | 2012 | 2423 | 0.090 |
Why?
|
Fibrinogen | 1 | 2014 | 892 | 0.090 |
Why?
|
Endoplasmic Reticulum | 1 | 2016 | 1129 | 0.090 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2014 | 1133 | 0.090 |
Why?
|
Extracellular Space | 1 | 2012 | 565 | 0.090 |
Why?
|
Hemolysis | 1 | 2012 | 419 | 0.090 |
Why?
|
Nitric Oxide | 1 | 2018 | 2146 | 0.080 |
Why?
|
Fucosyltransferases | 1 | 2009 | 118 | 0.080 |
Why?
|
Simvastatin | 1 | 2012 | 346 | 0.080 |
Why?
|
Male | 18 | 2020 | 364781 | 0.080 |
Why?
|
Ligands | 6 | 2010 | 3281 | 0.080 |
Why?
|
Crystallography | 2 | 2011 | 114 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2002 | 4642 | 0.080 |
Why?
|
Skin | 1 | 2002 | 4520 | 0.080 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2020 | 1890 | 0.080 |
Why?
|
Mesentery | 1 | 2009 | 202 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2019 | 10784 | 0.070 |
Why?
|
Sterol Esterase | 1 | 2007 | 39 | 0.070 |
Why?
|
Calcium Signaling | 3 | 2007 | 737 | 0.070 |
Why?
|
Sequence Homology, Amino Acid | 4 | 2007 | 2751 | 0.070 |
Why?
|
Antibodies | 3 | 2006 | 2425 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3816 | 0.070 |
Why?
|
Receptors, Cell Surface | 2 | 2008 | 2819 | 0.070 |
Why?
|
Structural Homology, Protein | 1 | 2007 | 87 | 0.070 |
Why?
|
Fura-2 | 1 | 2007 | 107 | 0.070 |
Why?
|
Sequence Alignment | 3 | 2007 | 2184 | 0.070 |
Why?
|
Endothelium, Lymphatic | 1 | 2007 | 63 | 0.070 |
Why?
|
Fluorescent Dyes | 2 | 2007 | 1924 | 0.070 |
Why?
|
Female | 14 | 2020 | 396943 | 0.070 |
Why?
|
Factor V | 1 | 2007 | 168 | 0.070 |
Why?
|
Phenotype | 3 | 2020 | 16712 | 0.070 |
Why?
|
Milk Proteins | 1 | 2007 | 162 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 2 | 2019 | 18048 | 0.060 |
Why?
|
Arteries | 1 | 2011 | 1126 | 0.060 |
Why?
|
Cysteine | 3 | 2006 | 895 | 0.060 |
Why?
|
RNA, Small Interfering | 1 | 2015 | 3437 | 0.060 |
Why?
|
Muscle, Skeletal | 2 | 2012 | 4984 | 0.060 |
Why?
|
Snails | 4 | 2006 | 21 | 0.060 |
Why?
|
Fibrinolysis | 2 | 2017 | 333 | 0.060 |
Why?
|
Membrane Proteins | 3 | 2015 | 7895 | 0.060 |
Why?
|
Platelet Membrane Glycoproteins | 1 | 2006 | 284 | 0.060 |
Why?
|
Hypercholesterolemia | 1 | 2012 | 1142 | 0.060 |
Why?
|
Blood Circulation | 1 | 2005 | 248 | 0.060 |
Why?
|
Receptors, IgG | 2 | 2006 | 564 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2882 | 0.060 |
Why?
|
Anticholesteremic Agents | 1 | 2012 | 972 | 0.060 |
Why?
|
Cloning, Molecular | 3 | 2006 | 4175 | 0.060 |
Why?
|
Chimera | 1 | 2005 | 454 | 0.060 |
Why?
|
Genetic Variation | 1 | 2019 | 6610 | 0.060 |
Why?
|
Cell Separation | 1 | 2009 | 1726 | 0.060 |
Why?
|
Amino Acid Substitution | 2 | 2011 | 1744 | 0.060 |
Why?
|
Mycobacterium tuberculosis | 1 | 2015 | 1931 | 0.060 |
Why?
|
Blood Cells | 1 | 2005 | 308 | 0.060 |
Why?
|
Cross-Linking Reagents | 2 | 2004 | 692 | 0.050 |
Why?
|
Vitamin K 2 | 1 | 2003 | 47 | 0.050 |
Why?
|
Bleeding Time | 2 | 2017 | 83 | 0.050 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2005 | 506 | 0.050 |
Why?
|
Macromolecular Substances | 1 | 2006 | 1435 | 0.050 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2005 | 458 | 0.050 |
Why?
|
Vitamin K 1 | 1 | 2003 | 47 | 0.050 |
Why?
|
Integrin alpha4 | 1 | 2003 | 88 | 0.050 |
Why?
|
Receptors, CXCR4 | 1 | 2007 | 729 | 0.050 |
Why?
|
Macrophages, Peritoneal | 1 | 2003 | 244 | 0.050 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2005 | 660 | 0.050 |
Why?
|
Microsomes | 1 | 2002 | 252 | 0.050 |
Why?
|
Escherichia coli | 1 | 2015 | 4220 | 0.050 |
Why?
|
Lymphatic Vessels | 1 | 2007 | 358 | 0.050 |
Why?
|
Monocytes | 1 | 2012 | 2591 | 0.050 |
Why?
|
Peptides | 5 | 2006 | 4368 | 0.050 |
Why?
|
Cell Culture Techniques | 1 | 2009 | 1669 | 0.050 |
Why?
|
Pyridazines | 1 | 2003 | 204 | 0.050 |
Why?
|
Cell Line | 5 | 2010 | 15609 | 0.050 |
Why?
|
Antibody Specificity | 1 | 2004 | 1065 | 0.050 |
Why?
|
Valine | 1 | 2003 | 410 | 0.050 |
Why?
|
Bacterial Proteins | 1 | 2015 | 3861 | 0.050 |
Why?
|
Protein Conformation | 4 | 2015 | 3973 | 0.050 |
Why?
|
Middle Aged | 7 | 2019 | 223418 | 0.050 |
Why?
|
COS Cells | 1 | 2002 | 1136 | 0.040 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 2 | 2016 | 397 | 0.040 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2012 | 2768 | 0.040 |
Why?
|
Time Factors | 5 | 2005 | 40271 | 0.040 |
Why?
|
Calcium Channels | 1 | 2004 | 624 | 0.040 |
Why?
|
Survival Analysis | 1 | 2012 | 10125 | 0.040 |
Why?
|
Mutation | 4 | 2019 | 30243 | 0.040 |
Why?
|
Hemostatics | 1 | 2002 | 246 | 0.040 |
Why?
|
Protein Structure, Secondary | 3 | 2007 | 1223 | 0.040 |
Why?
|
Aged | 6 | 2019 | 171520 | 0.040 |
Why?
|
Metals | 1 | 2004 | 713 | 0.040 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2005 | 828 | 0.040 |
Why?
|
Cyclic AMP | 1 | 2003 | 1468 | 0.040 |
Why?
|
Open Reading Frames | 1 | 2002 | 812 | 0.040 |
Why?
|
Oligodendroglia | 1 | 2003 | 538 | 0.040 |
Why?
|
Enzyme Activation | 3 | 2011 | 3594 | 0.040 |
Why?
|
Inflammation | 2 | 2012 | 10865 | 0.040 |
Why?
|
Ions | 3 | 2004 | 257 | 0.040 |
Why?
|
Abdominal Muscles | 1 | 2018 | 172 | 0.040 |
Why?
|
Graft vs Host Disease | 1 | 2010 | 3042 | 0.040 |
Why?
|
Plasmids | 1 | 2002 | 2269 | 0.040 |
Why?
|
Serpin E2 | 1 | 2017 | 48 | 0.040 |
Why?
|
Receptors, Urokinase Plasminogen Activator | 2 | 2008 | 76 | 0.040 |
Why?
|
Cell Communication | 1 | 2004 | 1662 | 0.040 |
Why?
|
Sulfhydryl Compounds | 1 | 2018 | 298 | 0.030 |
Why?
|
Biomedical Research | 1 | 2012 | 3463 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2016 | 22293 | 0.030 |
Why?
|
Hematopoiesis | 1 | 2005 | 2058 | 0.030 |
Why?
|
Half-Life | 1 | 2017 | 650 | 0.030 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2017 | 176 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2002 | 1797 | 0.030 |
Why?
|
Lymph Nodes | 1 | 2007 | 3472 | 0.030 |
Why?
|
Agar | 1 | 2015 | 51 | 0.030 |
Why?
|
Tryptophan | 2 | 2010 | 483 | 0.030 |
Why?
|
Down-Regulation | 1 | 2002 | 2944 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2019 | 2477 | 0.030 |
Why?
|
Allosteric Regulation | 1 | 2016 | 424 | 0.030 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2015 | 136 | 0.030 |
Why?
|
Mutant Proteins | 1 | 2016 | 489 | 0.030 |
Why?
|
Mycobacterium smegmatis | 1 | 2015 | 126 | 0.030 |
Why?
|
Electron Transport | 1 | 2015 | 211 | 0.030 |
Why?
|
Mass Spectrometry | 2 | 2015 | 2204 | 0.030 |
Why?
|
Rats | 2 | 2008 | 23839 | 0.030 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2015 | 275 | 0.030 |
Why?
|
Antigens, CD | 1 | 2004 | 4029 | 0.030 |
Why?
|
Prognosis | 1 | 2014 | 30028 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2017 | 1688 | 0.030 |
Why?
|
Protein Engineering | 1 | 2017 | 549 | 0.030 |
Why?
|
Molecular Weight | 2 | 2006 | 2173 | 0.030 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 2 | 2004 | 267 | 0.030 |
Why?
|
Genetic Vectors | 1 | 2002 | 3417 | 0.030 |
Why?
|
Toll-Like Receptor 6 | 1 | 2012 | 29 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2003 | 3145 | 0.020 |
Why?
|
Structure-Activity Relationship | 2 | 2011 | 3073 | 0.020 |
Why?
|
Bone Marrow | 3 | 2009 | 2929 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2019 | 4622 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2016 | 1339 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2019 | 1897 | 0.020 |
Why?
|
Pichia | 1 | 2011 | 49 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2003 | 3408 | 0.020 |
Why?
|
Models, Animal | 1 | 2017 | 2126 | 0.020 |
Why?
|
Cattle | 2 | 2007 | 3830 | 0.020 |
Why?
|
Receptors, LDL | 1 | 2012 | 491 | 0.020 |
Why?
|
Histidine | 1 | 2010 | 303 | 0.020 |
Why?
|
Bone Marrow Neoplasms | 1 | 2009 | 101 | 0.020 |
Why?
|
Administration, Oral | 1 | 2017 | 4041 | 0.020 |
Why?
|
Sialoglycoproteins | 1 | 2009 | 320 | 0.020 |
Why?
|
Lipoproteins, LDL | 1 | 2012 | 644 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2017 | 3735 | 0.020 |
Why?
|
Carcinoembryonic Antigen | 1 | 2009 | 338 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2012 | 677 | 0.020 |
Why?
|
Alleles | 1 | 2019 | 6890 | 0.020 |
Why?
|
Disease Progression | 1 | 2005 | 13655 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2015 | 1965 | 0.020 |
Why?
|
Toll-Like Receptor 4 | 1 | 2012 | 586 | 0.020 |
Why?
|
Escherichia coli Proteins | 1 | 2015 | 1061 | 0.020 |
Why?
|
Cholesterol Esters | 1 | 2007 | 72 | 0.020 |
Why?
|
Absorption | 1 | 2007 | 243 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2019 | 5308 | 0.020 |
Why?
|
Oligosaccharides | 1 | 2009 | 406 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2012 | 59680 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2016 | 2046 | 0.020 |
Why?
|
Platelet Membrane Glycoprotein IIb | 1 | 2006 | 51 | 0.020 |
Why?
|
Cytosol | 1 | 2010 | 889 | 0.020 |
Why?
|
Pseudomonas aeruginosa | 1 | 2015 | 1277 | 0.020 |
Why?
|
Receptors, Lymphocyte Homing | 1 | 2007 | 141 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2009 | 11206 | 0.020 |
Why?
|
Gene Expression | 1 | 2019 | 7605 | 0.020 |
Why?
|
Conus Snail | 1 | 2006 | 7 | 0.020 |
Why?
|
Epoprostenol | 1 | 2007 | 248 | 0.020 |
Why?
|
Phospholipids | 1 | 2010 | 783 | 0.020 |
Why?
|
Hydrogen Bonding | 1 | 2006 | 292 | 0.020 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2005 | 97 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2016 | 4780 | 0.020 |
Why?
|
Hirudins | 1 | 2006 | 179 | 0.010 |
Why?
|
Peptide Biosynthesis | 1 | 2004 | 52 | 0.010 |
Why?
|
Amino Acid Motifs | 1 | 2007 | 930 | 0.010 |
Why?
|
Phosphotransferases | 1 | 2005 | 303 | 0.010 |
Why?
|
Duodenum | 1 | 2007 | 495 | 0.010 |
Why?
|
Sodium-Calcium Exchanger | 1 | 2004 | 90 | 0.010 |
Why?
|
Surface Properties | 1 | 2007 | 1168 | 0.010 |
Why?
|
3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2003 | 50 | 0.010 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2003 | 20 | 0.010 |
Why?
|
Adult | 3 | 2019 | 223542 | 0.010 |
Why?
|
Circular Dichroism | 1 | 2004 | 338 | 0.010 |
Why?
|
Neurons | 1 | 2003 | 9504 | 0.010 |
Why?
|
gamma-Glutamylcyclotransferase | 1 | 2003 | 11 | 0.010 |
Why?
|
Cations | 1 | 2004 | 240 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2004 | 3783 | 0.010 |
Why?
|
HIV Envelope Protein gp120 | 1 | 2007 | 925 | 0.010 |
Why?
|
Cystine | 1 | 2003 | 93 | 0.010 |
Why?
|
Hydrolysis | 1 | 2004 | 654 | 0.010 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2003 | 213 | 0.010 |
Why?
|
src-Family Kinases | 1 | 2005 | 539 | 0.010 |
Why?
|
Whole-Body Irradiation | 1 | 2003 | 434 | 0.010 |
Why?
|
Risk Factors | 1 | 2009 | 74915 | 0.010 |
Why?
|
DNA Primers | 1 | 2006 | 2826 | 0.010 |
Why?
|
T-Lymphocyte Subsets | 1 | 2010 | 1814 | 0.010 |
Why?
|
Signal Transduction | 1 | 2005 | 23638 | 0.010 |
Why?
|
Protein Precursors | 1 | 2006 | 1133 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 2004 | 694 | 0.010 |
Why?
|
Isoenzymes | 1 | 2006 | 1685 | 0.010 |
Why?
|
Insulin | 1 | 2016 | 6606 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2011 | 2594 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2006 | 1998 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2010 | 4834 | 0.010 |
Why?
|
Inflammation Mediators | 1 | 2010 | 1892 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2010 | 6241 | 0.010 |
Why?
|
Electrophysiology | 1 | 2004 | 1266 | 0.010 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2003 | 692 | 0.010 |
Why?
|
Carotid Arteries | 1 | 2005 | 943 | 0.010 |
Why?
|
Lysophospholipids | 1 | 2003 | 338 | 0.010 |
Why?
|
Abdomen | 1 | 2007 | 1136 | 0.010 |
Why?
|
Glutathione | 1 | 2003 | 587 | 0.010 |
Why?
|
Macrophage Activation | 1 | 2003 | 556 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2004 | 1543 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 21552 | 0.010 |
Why?
|
Arginine | 1 | 2003 | 923 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2004 | 2488 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 65409 | 0.010 |
Why?
|
Multiprotein Complexes | 1 | 2005 | 1112 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2009 | 4931 | 0.010 |
Why?
|
Protons | 1 | 2004 | 1113 | 0.010 |
Why?
|
Glutamic Acid | 1 | 2004 | 1192 | 0.010 |
Why?
|
Cell Death | 1 | 2003 | 1684 | 0.010 |
Why?
|
Tetrazoles | 1 | 2003 | 922 | 0.010 |
Why?
|
Risk | 1 | 2010 | 9642 | 0.010 |
Why?
|
Infant | 1 | 2019 | 36497 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39430 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2006 | 6091 | 0.010 |
Why?
|
Spinal Cord | 1 | 2005 | 1814 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2005 | 3169 | 0.010 |
Why?
|
Neuroprotective Agents | 1 | 2003 | 960 | 0.010 |
Why?
|
Child, Preschool | 1 | 2019 | 42623 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2016 | 16029 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2015 | 7471 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2005 | 2434 | 0.010 |
Why?
|
Cell Division | 1 | 2003 | 4479 | 0.010 |
Why?
|
Antioxidants | 1 | 2003 | 1678 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2003 | 2150 | 0.010 |
Why?
|
Liver | 1 | 2009 | 7575 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2009 | 4362 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2005 | 4534 | 0.010 |
Why?
|
Young Adult | 1 | 2019 | 60045 | 0.010 |
Why?
|
Survival Rate | 1 | 2007 | 12875 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2004 | 4572 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2003 | 8201 | 0.010 |
Why?
|
Child | 1 | 2019 | 80863 | 0.010 |
Why?
|
Adolescent | 1 | 2019 | 89168 | 0.010 |
Why?
|
Stem Cells | 1 | 2003 | 3538 | 0.010 |
Why?
|
HIV-1 | 1 | 2007 | 6966 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2005 | 10494 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2005 | 17149 | 0.000 |
Why?
|
T-Lymphocytes | 1 | 2005 | 10273 | 0.000 |
Why?
|
United States | 1 | 2012 | 73121 | 0.000 |
Why?
|
Brain | 1 | 2005 | 27438 | 0.000 |
Why?
|